These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 19205734)
1. Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma. Yamamoto T; Ohno T; Wakahara K; Nagano A; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Shimizu K J Cancer Res Clin Oncol; 2009 Aug; 135(8):1125-36. PubMed ID: 19205734 [TBL] [Abstract][Full Text] [Related]
2. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma. Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725 [TBL] [Abstract][Full Text] [Related]
3. Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways. Nan X; Wang J; Cheng H; Yin Z; Sheng J; Qiu B; Lau CC; Yustein JT; Zhao H; Wong STC Cancer Lett; 2020 Jan; 469():195-206. PubMed ID: 31672491 [TBL] [Abstract][Full Text] [Related]
4. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model. Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560 [TBL] [Abstract][Full Text] [Related]
5. Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors. Loganathan SN; Tang N; Holler AE; Wang N; Wang J Mol Cancer Ther; 2019 May; 18(5):929-936. PubMed ID: 30926641 [TBL] [Abstract][Full Text] [Related]
6. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma. Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270 [TBL] [Abstract][Full Text] [Related]
7. Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation. Silvany RE; Eliazer S; Wolff NC; Ilaria RL Oncogene; 2000 Sep; 19(39):4523-30. PubMed ID: 11002425 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet-derived growth factor-induced cell growth signaling by a short interfering RNA for EWS-Fli1 via down-regulation of phospholipase D2 in Ewing sarcoma cells. Nozawa S; Ohno T; Banno Y; Dohjima T; Wakahara K; Fan DG; Shimizu K J Biol Chem; 2005 Jul; 280(30):27544-51. PubMed ID: 15919668 [TBL] [Abstract][Full Text] [Related]
9. PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1. Giorgi C; Boro A; Rechfeld F; Lopez-Garcia LA; Gierisch ME; Schäfer BW; Niggli FK Oncotarget; 2015 Oct; 6(30):28895-910. PubMed ID: 26336820 [TBL] [Abstract][Full Text] [Related]
10. RETRACTED: Combining PARP-1 inhibition and radiation in Ewing sarcoma results in lethal DNA damage. Lee HJ; Yoon C; Schmidt B; Park DJ; Zhang AY; Erkizan HV; Toretsky JA; Kirsch DG; Yoon SS Mol Cancer Ther; 2013 Nov; 12(11):2591-600. PubMed ID: 23966622 [TBL] [Abstract][Full Text] [Related]
11. Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target. Herrero-Martín D; Osuna D; Ordóñez JL; Sevillano V; Martins AS; Mackintosh C; Campos M; Madoz-Gúrpide J; Otero-Motta AP; Caballero G; Amaral AT; Wai DH; Braun Y; Eisenacher M; Schaefer KL; Poremba C; de Alava E Br J Cancer; 2009 Jul; 101(1):80-90. PubMed ID: 19491900 [TBL] [Abstract][Full Text] [Related]
12. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Prieur A; Tirode F; Cohen P; Delattre O Mol Cell Biol; 2004 Aug; 24(16):7275-83. PubMed ID: 15282325 [TBL] [Abstract][Full Text] [Related]
13. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas. Zhang J; Hu S; Schofield DE; Sorensen PH; Triche TJ Cancer Res; 2004 Sep; 64(17):6026-34. PubMed ID: 15342383 [TBL] [Abstract][Full Text] [Related]
14. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma. Stegmaier K; Wong JS; Ross KN; Chow KT; Peck D; Wright RD; Lessnick SL; Kung AL; Golub TR PLoS Med; 2007 Apr; 4(4):e122. PubMed ID: 17425403 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway. Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300 [TBL] [Abstract][Full Text] [Related]
16. Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line. Dohjima T; Lee NS; Li H; Ohno T; Rossi JJ Mol Ther; 2003 Jun; 7(6):811-6. PubMed ID: 12788655 [TBL] [Abstract][Full Text] [Related]